In 2010, Jeffrey B. Kindler earned $11.82M in total compensation at Pfizer, including $1.80M salary, $3.25M bonus and $6.31M in stock. Led Pfizer as CEO for 4 years.
Compensation History
Annual executive compensation data for Jeffrey B. Kindler, including salary, bonuses, and stock awards.
Year
2010
Total Compensation
$11.82M
Salary
$1.80M
Bonus
$3.25M
Other
$451.08K
Salary
$1.80MBoard Justification
The compensation philosophy aims to align executive compensation with company performance and shareholder interests, targeting the median compensation of peer companies.
Bonus
$3.25MBoard Justification
The bonus was determined based on performance metrics and paid at 120% of the target level award.
Other Compensation
$451.08KBoard Justification
Includes severance payment and accrued vacation pay.
Restricted Stock
Board Justification
The RSUs vested upon retirement and were settled in shares of Pfizer stock.
Performance Metrics
The performance metrics included Total Revenue, Adjusted Diluted EPS, and Cash Flow from Operations.
Jeffrey B. Kindler
Ex-CEO of Pfizer
Education
B.A. degree, summa cum laude, from Tufts University in 1977 and J.D. degree, magna cum laude, from Harvard Law School in 1980.
Field of Expertise
Legal & Compliance - Law
Sector of Economy
Healthcare
Born
May 13, 1955 - 70 years ago
CEO of Pfizer for
4 years 4 months (Jul 2006 - Dec 2010)
Previous Experience
Chairman and CEO of Boston Market Corporation, President of Partner Brands, Executive Vice President, Corporate Relations and General Counsel of McDonald's Corporation.
Other Pfizer CEOs
Holdings
Track Jeffrey B. Kindler's stock holdings and portfolio value over time.
Insider Trading
Jeffrey B. Kindler's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Jeffrey B. Kindler with competitor CEOs and industry peers.
Daniel O'Day
CEO of Gilead Sciences
2024 Compensation
Stock
$18.79M
Salary
$1.77M
Bonus
$0.00
Other
$1.34M
Total Holdings
$23.48M
Robert M. Davis
CEO of Merck & Co.
2024 Compensation
Stock
$18.10M
Salary
$1.62M
Bonus
$0.00
Other
$561.11K
Total Holdings
$43.45M
Stanley C. Erck
CEO of Novavax
2023 Compensation
Stock
$129.78K
Salary
$50.90K
Bonus
$0.00
Other
$3.83M
Total Holdings
$4.60M
Joaquin Duato
CEO of Johnson & Johnson
2024 Compensation
Stock
$7.13M
Salary
$1.60M
Bonus
$3.22M
Other
$1.08M
Total Holdings
$1.09M
Stéphane Bancel
CEO of Moderna
2023 Compensation
Stock
$0.00
Salary
$1.58M
Bonus
$1.91M
Other
$1.07M
Total Holdings
$335.71M
Christopher Boerner
CEO of Bristol-Myers Squibb
2023 Compensation
Stock
$0.00
Salary
$1.50M
Bonus
$0.00
Other
$311.64K
Total Holdings
$7.39M